Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

A San Francisco fund has doubled stake in AMLN

|Includes: Bristol-Myers Squibb Company (BMY)

Partner Fund Management is a San Francisco fund with more than $1 billion in holdings, including large health care and technology positions. In a filing on Friday, Partner revealed that it raised its stake in Amylin to 7.1 million.

Discalimer: MD Capital Management owns AMLN